Literature DB >> 19196820

Increased T-regulatory cells within lymphocyte follicles in moderate COPD.

J Plumb1, L J C Smyth, H R Adams, J Vestbo, A Bentley, S D Singh.   

Abstract

Lymphoid follicles in the lung parenchyma are a characteristic feature of chronic obstructive pulmonary disease (COPD). There are reports of altered CD4 T-regulatory cell numbers in COPD lungs, but the location of these cells within COPD lung tissue specific follicles has not been investigated. The presence of CD4(+)FOXP3(+) T-regulatory cells was assessed in surgically resected lung tissue from 12 COPD patients, 11 smokers with normal lung function and seven nonsmokers by combined immunofluorescence and immunohistochemistry. Organised lymphoid follicles were observed in all three groups of patients, as well as lymphoid clusters lacking organisation. The percentage of CD4 cells that were T-regulatory cells were significantly increased (p = 0.02) within COPD (16%) follicles compared with smokers (10%) and nonsmokers (8%). In contrast, there was no change (p>0.05) in the percentage of T-regulatory cells in clusters or the subepithelium between groups. Lymphoid follicles in COPD patients have increased T-regulatory cells. Therefore, T-regulatory activity may be altered within COPD lymphoid follicles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196820     DOI: 10.1183/09031936.00100708

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease.

Authors:  Dino B A Tan; Teck-Hui Teo; Abdul M Setiawan; Nathanael E Ong; Maja Zimmermann; Patricia Price; Lea-Ann S Kirkham; Yuben P Moodley
Journal:  Immunology       Date:  2017-03-20       Impact factor: 7.397

2.  Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers.

Authors:  W M Chatila; G J Criner; W W Hancock; T Akimova; B Moldover; J-K Chang; W Cornwell; M Santerre; T J Rogers
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.

Authors:  Manish Bodas; Taehong Min; Steven Mazur; Neeraj Vij
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

Review 4.  Lung Dendritic Cells: Shaping Immune Responses throughout Chronic Obstructive Pulmonary Disease Progression.

Authors:  Christine M Freeman; Jeffrey L Curtis
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

Review 5.  Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Tariq A Bhat; Louis Panzica; Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Ann Am Thorac Soc       Date:  2015-11

6.  T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.

Authors:  Suresh Gopi Kalathil; Amit Anand Lugade; Vandana Pradhan; Austin Miller; Ganapathi Iyer Parameswaran; Sanjay Sethi; Yasmin Thanavala
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

7.  Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation.

Authors:  Saskia Braber; Paul A J Henricks; Frans P Nijkamp; Aletta D Kraneveld; Gert Folkerts
Journal:  Respir Res       Date:  2010-07-22

8.  Expansion of CD4+CD25+ helper T cells without regulatory function in smoking and COPD.

Authors:  Ester Roos-Engstrand; Jamshid Pourazar; Annelie F Behndig; Anders Bucht; Anders Blomberg
Journal:  Respir Res       Date:  2011-06-08

9.  Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes.

Authors:  R Zaynagetdinov; G T Stathopoulos; T P Sherrill; D-S Cheng; A G McLoed; J A Ausborn; V V Polosukhin; L Connelly; W Zhou; B Fingleton; R S Peebles; L S Prince; F E Yull; T S Blackwell
Journal:  Oncogene       Date:  2011-10-17       Impact factor: 9.867

10.  IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice.

Authors:  Etsuko Kurimoto; Nobuaki Miyahara; Arihiko Kanehiro; Koichi Waseda; Akihiko Taniguchi; Genyo Ikeda; Hikari Koga; Hisakazu Nishimori; Yasushi Tanimoto; Mikio Kataoka; Yoichiro Iwakura; Erwin W Gelfand; Mitsune Tanimoto
Journal:  Respir Res       Date:  2013-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.